<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Surg Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Ann Surg Oncol</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Annals of Surgical Oncology</journal-title></journal-title-group><issn pub-type="ppub">1068-9265</issn><issn pub-type="epub">1534-4681</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11976740</article-id><article-id pub-id-type="pmcid-ver">PMC11976740.1</article-id><article-id pub-id-type="pmcaid">11976740</article-id><article-id pub-id-type="pmcaiid">11976740</article-id><article-id pub-id-type="pmid">39794676</article-id><article-id pub-id-type="doi">10.1245/s10434-024-16861-x</article-id><article-id pub-id-type="publisher-id">16861</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>ASO Author Reflections</subject></subj-group></article-categories><title-group><article-title>ASO Author Reflections: New Persistent Benzodiazepine Use following Cancer Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Rashid</surname><given-names initials="Z">Zayed</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7994-9870</contrib-id><name name-style="western"><surname>Pawlik</surname><given-names initials="TM">Timothy M.</given-names></name><degrees>MD, PhD, MPH, MTS, MBA</degrees><address><email>tim.pawlik@osumc.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rs6vg23</institution-id><institution-id institution-id-type="GRID">grid.261331.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 7943</institution-id><institution>Department of Surgery, Wexner Medical Centre, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, </institution><institution> The Ohio State University, </institution></institution-wrap>Columbus, OH USA </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>32</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">486196</issue-id><fpage>3441</fpage><lpage>3442</lpage><history><date date-type="received"><day>20</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>25</day><month>12</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>10</day><month>01</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>09</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-09 10:25:49.303"><day>09</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10434_2024_Article_16861.pdf"/><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Society of Surgical Oncology 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Past</title><p id="Par1">Benzodiazepines rank among the most commonly prescribed psychotropic medications in high income countries and are known for their sedative, hypnotic, and anxiolytic properties.<sup><xref ref-type="bibr" rid="CR1">1</xref></sup> These characteristics make benzodiazepine useful among patients undergoing surgery, particularly individuals with cancer.<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> However, the stressor characteristics of a cancer diagnosis and treatment can place patients at risk of aversive coping mechanisms.<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> Of note, patients with newly prescribed perioperative benzodiazepines can continue to use these drugs for durations longer than initially intended.<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> This condition is often referred to as new persistent benzodiazepine use (NPBU).<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> Patients with cancer may be at particular risk of NPBU as they often require higher doses to manage conditions such as therapy related nausea or vomiting.<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> As such, the current study sought to assess NPBU among patients undergoing a surgical procedure for cancer, and to identify risk factors associated with NPBU.<sup><xref ref-type="bibr" rid="CR2">2</xref></sup></p></sec><sec id="Sec2"><title>Present</title><p id="Par2">Among 34,637 patients who underwent resection of primary cancer of breast, lung, esophagus, stomach, pancreas, liver, gall bladder, colon, rectum, or prostate, almost 8% developed NPBU. Patients with mental health illnesses, such as depression (12.7% versus 7.2%) or anxiety (15.5% versus 7.7%) were more likely to develop NPBU. Similarly, patients who underwent neoadjuvant therapy (chemotherapy: 88.1% versus 61.1%; radiotherapy: 33.8% versus 24.0%) and adjuvant therapy (chemotherapy: 79.4% versus 44.4%; radiotherapy: 17.2% versus 10.5%) more often developed NPBU. Of note, the development of concurrent new persistent use of opioids was associated with 84% higher odds of concomitant NPBU. Interestingly, patients with new perioperative benzodiazepine exposure versus non-exposure had two-fold higher odds of NPBU [odds ratio (OR) 2.00, 95% confidence interval (CI) 1.68&#8211;2.38]. This association was consistent across high-versus-low doses of perioperative benzodiazepine (ref. dose of &lt; 10.5 LME; dose of 10.5&#8211;19.9 LME: OR 1.71, 95% CI 1.40&#8211;2.10; dose of 20.0&#8211;32.0 LME: OR 1.88, 95% CI 1.55&#8211;2.29; dose of &gt; 32.0 LME: OR 2.42, 95% CI 2.01&#8211;2.92).</p></sec><sec id="Sec3"><title>Future</title><p id="Par3">Surgical patients, particularly individuals with malignancy, can often have multiple co-morbidities and complex care needs.<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> There can be a high prevalence of behavioral disorders (e.g., eating or sleeping disorders), as well as mental health problems (e.g., depression or anxiety) among these individuals.<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> These morbidities in turn can lead to higher utilization of benzodiazepines following surgery and development of surgical complications, such as NPBU.<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> As such, multidisciplinary management of these patients with counseling services can mitigate the risk of such complications.<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> Similarly, a vast majority of patients can have leftover pills from prescriptions related to the&#160;index surgical admission.<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> This reservoir of unneeded medications can act as a major contributor to narcotic diversion among patients.<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> NPBU can be addressed through implementation of programs to encourage convenient and safe disposal of leftover medications.<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> Furthermore, alternatives to benzodiazepine should be employed whenever possible. When benzodiazepines are unavoidable, these drugs should be used with lower doses and shorter durations.<sup><xref ref-type="bibr" rid="CR2">2</xref></sup></p></sec></body><back><fn-group><fn><p>This article refers to: Rashid Z, Woldesenbet S, Khalil M, et al. Perioperative Benzodiazepine Exposure Impacts Risk of New Persistent Benzodiazepine Use Among Patients with Cancer. Annals Surgical Oncology. (2024). 10.1245/s10434-024-16788-3</p></fn><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="funding-information"><title>Funding</title><p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></notes><notes notes-type="COI-statement"><title>Disclosure</title><p>The authors declare no conflicts of interest.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>L</given-names></name><name name-style="western"><surname>Meeks</surname><given-names>TW</given-names></name><name name-style="western"><surname>Blazes</surname><given-names>CK</given-names></name></person-group><article-title>Complex persistent benzodiazepine dependence&#8212;when benzodiazepine deprescribing goes awry</article-title><source>JAMA Psychiatry.</source><year>2022</year><volume>79</volume><issue>7</issue><fpage>639</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2022.1150</pub-id><pub-id pub-id-type="pmid">35583897</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Peng L, Meeks TW, Blazes CK. Complex persistent benzodiazepine dependence&#8212;when benzodiazepine deprescribing goes awry. <italic toggle="yes">JAMA Psychiatry</italic>. 2022;79(7):639&#8211;40. 10.1001/jamapsychiatry.2022.1150.<pub-id pub-id-type="pmid">35583897</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamapsychiatry.2022.1150</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rashid</surname><given-names>Z</given-names></name><name name-style="western"><surname>Woldesenbet</surname><given-names>S</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>M</given-names></name><etal/></person-group><article-title>Perioperative benzodiazepine exposure impacts risk of new persistent benzodiazepine use among patients with cancer</article-title><source>Ann Surg Oncol.</source><year>2024</year><pub-id pub-id-type="doi">10.1245/s10434-024-16788-3</pub-id><pub-id pub-id-type="pmid">39733079</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Rashid Z, Woldesenbet S, Khalil M, et al. Perioperative benzodiazepine exposure impacts risk of new persistent benzodiazepine use among patients with cancer. <italic toggle="yes">Ann Surg Oncol</italic>. 2024. 10.1245/s10434-024-16788-3.<pub-id pub-id-type="pmid">39733079</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1245/s10434-024-16788-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katayama</surname><given-names>ES</given-names></name><name name-style="western"><surname>Woldesenbet</surname><given-names>S</given-names></name><name name-style="western"><surname>Munir</surname><given-names>MM</given-names></name><etal/></person-group><article-title>effect of behavioral health disorders on surgical outcomes in cancer patients</article-title><source>J Am Coll Surg.</source><year>2024</year><volume>238</volume><issue>4</issue><fpage>625</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1097/XCS.0000000000000954</pub-id><pub-id pub-id-type="pmid">38420963</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Katayama ES, Woldesenbet S, Munir MM, et al. effect of behavioral health disorders on surgical outcomes in cancer patients. <italic toggle="yes">J Am Coll Surg</italic>. 2024;238(4):625&#8211;33. 10.1097/XCS.0000000000000954.<pub-id pub-id-type="pmid">38420963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/XCS.0000000000000954</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakamoto</surname><given-names>MR</given-names></name><name name-style="western"><surname>Eguchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Azelby</surname><given-names>CM</given-names></name><etal/></person-group><article-title>New persistent opioid and benzodiazepine use after curative-intent treatment in patients with breast cancer</article-title><source>J Natl Compr Canc Netw.</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>29</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.6004/jnccn.2020.7612</pub-id><pub-id pub-id-type="pmid">33406490</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Sakamoto MR, Eguchi M, Azelby CM, et al. New persistent opioid and benzodiazepine use after curative-intent treatment in patients with breast cancer. <italic toggle="yes">J Natl Compr Canc Netw</italic>. 2021;19(1):29&#8211;38. 10.6004/jnccn.2020.7612.<pub-id pub-id-type="pmid">33406490</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.6004/jnccn.2020.7612</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalil</surname><given-names>M</given-names></name><name name-style="western"><surname>Woldesenbet</surname><given-names>S</given-names></name><name name-style="western"><surname>Munir</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Surgical opioid prescription and the risk of opioid initiation among opioid-naive households</article-title><source>Am J Surg.</source><year>2025</year><volume>241</volume><fpage>116029</fpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2024.116029</pub-id><pub-id pub-id-type="pmid">39500227</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Khalil M, Woldesenbet S, Munir MM, et al. Surgical opioid prescription and the risk of opioid initiation among opioid-naive households. <italic toggle="yes">Am J Surg</italic>. 2025;241:116029. 10.1016/j.amjsurg.2024.116029.<pub-id pub-id-type="pmid">39500227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjsurg.2024.116029</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>